Hypofractionated radiotherapy with simultaneous integrated boost (SIB) plus temozolomide in good prognosis patients with glioblastoma: a multicenter phase II study by the Brain Study Group of the Italian Association of Radiation Oncology (AIRO)

Publication | Closed Access

DOI

Citations

References

2017

Year

Silvia Scoccianti, Marco Krengli, L. Marrazzo, Stefano Maria Magrini, Beatrice Detti, Vincenzo Fusco, Luigi Pirtoli, D. Doino, Alba Fiorentino, Laura Masini,

La radiologia medica

Neuro-oncologyGliomaRadiation TherapyItalian AssociationMedicineHigh-grade GliomasBrain Study GroupMri-guided Radiation TherapyOncologyRadiation OncologyRadiologyHealth Sciences